Back

CD&R appoints Novartis Chair Giovanni Caforio as operating advisor

Verifying
  • CD&R appointed Giovanni Caforio as an Operating Advisor to its funds.
  • BMS launched 12 medicines and tripled revenue during Caforio's eight-year CEO tenure.
  • Caforio has chaired Novartis since 2025 after stepping down from BMS in 2023.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.